HBOT Applications

FDA-Approved Level A

Diabetic Foot Ulcers

Most recognized HBOT application. Significantly improves complete healing rates in ischemic diabetic foot ulcers, reducing amputation rates when combined with standard wound care.

Protocol

Pressure

2.0 – 2.4 ATA

Duration

90 min

Sessions

30 – 40

Frequency

Once daily, 5×/week

Evidence basis: UHMS / FDA-Approved

References: 9 13

Investigational / Preclinical Level C

Diabetic Nephropathy

Preclinical and early clinical studies demonstrate HBOT suppresses biomarkers of cell stress and kidney injury in diabetic models, suggesting renoprotective effects.

Protocol

Pressure

2.0 – 2.4 ATA

Duration

90 min

Sessions

20 – 30

Frequency

Once daily, 5×/week

Evidence basis: Clinical Research

References: 18

Investigational / Preclinical Level C

Insulin Sensitivity & Metabolic Syndrome

Emerging evidence suggests HBOT may improve insulin sensitivity and reduce metabolic syndrome markers through enhanced mitochondrial function and reduced inflammation.

Protocol

Pressure

2.0 ATA

Duration

90 min

Sessions

20 – 30

Frequency

Once daily, 5×/week

Evidence basis: Investigational

References: 18